ClinicalTrials.gov
ClinicalTrials.gov Menu

Double-blind, Randomized, Placebo-controlled Phase 3 Study of Etanercept in the Treatment of Psoriatic Arthritis and Psoriasis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00317499
Recruitment Status : Completed
First Posted : April 25, 2006
Last Update Posted : December 23, 2010
Sponsor:
Collaborator:
Immunex Corporation
Information provided by:
Amgen

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 2002
  Actual Study Completion Date : July 2002
Publications of Results:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):